Pancreatic Pathology — MCQs

A 65-year-old woman presents with a 5-week history of yellow skin and sclera, anorexia, and epigastric pain. Her past medical history is significant for insulin-dependent diabetes mellitus. She smoked one pack of cigarettes a day for the past 20 years. Physical examination reveals jaundice and a palpable gallbladder. Laboratory studies show a serum bilirubin level of 10 mg/dL, mostly in the conjugated form, and an elevated alkaline phosphatase (260 U/L). A CT scan of the abdomen discloses a mass in the head of the pancreas and multiple nodules in the liver measuring up to 3 cm. Which of the following is the most likely cause of jaundice in this patient?

Q7Medium

A 45-year-old woman complains of right upper quadrant abdominal pain, weight loss, dry mouth, increased urine production, and foul-smelling fatty stools. She has a recent history of mild diabetes mellitus. Abdominal ultrasound examination reveals gallstones and a solitary 1.5-cm mass in the pancreas. Which of the following hormones would most likely be elevated in the blood of this patient?

Q8Easy

Mucoviscidosis is most commonly related to which of the following conditions?

Q9Easy

What is the commonest type of pancreatic tumour?

Q10Medium

Which of the following statements about autoimmune pancreatitis are true?

Pancreatic Pathology Indian Medical PG Practice Questions and MCQs

Question 1: What is the difference between acute and chronic pancreatitis?

A. Acute pancreatitis has reversible changes. (Correct Answer)
B. Alcohol causes only acute pancreatitis.
C. Chronic pancreatitis shows no signs of inflammation.
D. Acute pancreatitis affects mainly the younger population.

Explanation: ### Explanation **1. Why Option A is Correct:** The fundamental distinction between acute and chronic pancreatitis lies in the **reversibility of parenchymal damage**. [1] * **Acute Pancreatitis** is characterized by an acute inflammatory response to premature activation of pancreatic enzymes (trypsinogen to trypsin). [3] If the underlying cause (e.g., gallstones) is removed and complications are managed, the pancreas can return to its normal histological and functional state. * **Chronic Pancreatitis** involves irreversible destruction of the exocrine parenchyma, fibrosis, and, in late stages, destruction of endocrine parenchyma (Islets of Langerhans). [1] **2. Why the Other Options are Incorrect:** * **Option B:** Alcohol is a major cause of **both** acute and chronic pancreatitis. [3][4] In fact, chronic alcohol consumption is the most common cause of chronic pancreatitis in adults. [1] * **Option C:** Chronic pancreatitis is defined by **prolonged inflammation** associated with irreversible morphologic changes. [1] While the cellular infiltrate differs (lymphocytes and macrophages vs. neutrophils), inflammation is a core component of the disease process. * **Option D:** There is no strict age-based rule. While acute pancreatitis due to gallstones often affects middle-aged individuals, and chronic pancreatitis often affects middle-aged men (alcohol-related), both can occur across various age groups depending on the etiology (e.g., cystic fibrosis in children). [3] **3. NEET-PG High-Yield Pearls:** * **Hallmark of Chronic Pancreatitis:** Fibrosis and atrophy of acini. [1] The most specific imaging finding is **pancreatic calcification**. * **Morphology of Acute Pancreatitis:** Look for **fat necrosis** (chalky white deposits due to calcium soap formation) and **liquefactive necrosis** of the parenchyma. * **Key Enzyme:** Trypsin is the "master switch" that activates other proenzymes (proelastase, prophospholipase). [3] * **Sentinel Event:** Intracellular activation of enzymes within **acinar cells**. [2][3] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 889-895. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 890-891. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 889-890. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 406-407.

Question 2: What is the most common primary site of malignancy that leads to secondary metastases in the pancreas?

A. Lung (Correct Answer)
B. Breast
C. Colon
D. Stomach

Explanation: **Explanation:** Secondary (metastatic) tumors of the pancreas are relatively rare compared to primary pancreatic adenocarcinoma. However, when they occur, they most commonly originate from the **Lung**. **1. Why Lung is Correct:** The lung is the most frequent primary site for pancreatic metastases, followed closely by the kidney (Renal Cell Carcinoma), breast, and melanoma. Lung cancer, particularly Small Cell Lung Cancer (SCLC) and Adenocarcinoma, has a high propensity for hematogenous spread [1]. In autopsy series, the pancreas is involved in approximately 5–10% of patients who die from metastatic lung cancer. **2. Analysis of Incorrect Options:** * **Breast (Option B):** While breast cancer is a common source of systemic metastasis, it ranks behind lung and kidney as a primary source for pancreatic secondaries. * **Colon (Option C):** Colorectal cancer typically metastasizes to the liver via the portal venous system [4]. Pancreatic involvement is uncommon and usually occurs via direct extension rather than hematogenous spread. * **Stomach (Option D):** Gastric cancer usually involves the pancreas through **direct contiguous spread** (especially from the posterior wall) rather than true distant metastasis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Most common primary pancreatic malignancy:** Ductal Adenocarcinoma (Head > Body > Tail) [2]. * **Most common source of pancreatic metastasis (Autopsy):** Lung Cancer. * **Most common source of pancreatic metastasis (Surgical/Clinical series):** Renal Cell Carcinoma (RCC). *Note: If both Lung and RCC are options, Lung is the standard textbook answer for "most common primary site."* * **Imaging:** Metastatic lesions are often hypervascular (especially RCC) or multiple, whereas primary pancreatic cancer is typically a solitary, hypovascular mass [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 898-899. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, p. 897. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 408-409.

Question 3: Intraductal papillary mucinous neoplasm is a precursor of which of the following entities?

A. Mucinous cystic neoplasm
B. Mucinous non-cystic neoplasm
C. Ductal adenocarcinoma (Correct Answer)
D. Solid pseudopapillary neoplasm

Explanation: **Explanation:** **Intraductal Papillary Mucinous Neoplasm (IPMN)** is a macroscopic, mucin-producing epithelial neoplasm arising within the main pancreatic duct or its branches. It is a well-recognized **precursor lesion** that follows a progressive dysplasia-carcinoma sequence, eventually leading to **Invasive Ductal Adenocarcinoma** [1]. **Why Ductal Adenocarcinoma is correct:** Pancreatic ductal adenocarcinoma (PDAC) typically arises from three precursor lesions [1]: 1. **PanIN (Pancreatic Intraepithelial Neoplasia):** Microscopic (<1cm), most common. 2. **IPMN:** Macroscopic, involving the ductal system. 3. **MCN (Mucinous Cystic Neoplasm):** Macroscopic, characterized by "ovarian-type" stroma. IPMNs are characterized by papillary growths and can be categorized into low, intermediate, or high-grade dysplasia before progressing to invasive ductal adenocarcinoma. **Why other options are incorrect:** * **Mucinous Cystic Neoplasm (MCN):** This is a distinct precursor lesion itself, not a consequence of IPMN. It occurs almost exclusively in females and is located in the tail/body of the pancreas. * **Mucinous non-cystic neoplasm:** This is not a standard pathological entity in the context of pancreatic precursor progression. * **Solid Pseudopapillary Neoplasm (SPN):** This is a low-grade malignant tumor typically seen in young women. It arises from pluripotent cells and follows a different molecular pathway (̢-catenin mutations), unrelated to the IPMN-adenocarcinoma sequence. **High-Yield Clinical Pearls for NEET-PG:** * **Location:** IPMNs most commonly involve the **head of the pancreas**. * **Gender:** Unlike MCNs (female-dominant), IPMNs occur more frequently in **men**. * **Imaging:** Classic "fish-mouth" appearance of the Ampulla of Vater due to profuse mucin secretion. * **Molecular Genetics:** IPMNs are frequently associated with **GNAS** and **KRAS** mutations [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 897-901.

Question 4: Which of the following conditions has the highest risk of progressing to pancreatic carcinoma?

A. Intraductal papillary mucinous neoplasms (Correct Answer)
B. Pseudopancreatic cyst
C. Serous cystic neoplasms
D. Mucinous cystic neoplasms

Explanation: **Explanation:** The progression of pancreatic cysts to malignancy depends on the presence of a mucinous lining and specific genetic mutations. [1] **1. Why Intraductal Papillary Mucinous Neoplasms (IPMNs) are correct:** IPMNs are mucin-producing epithelial neoplasms that arise within the main pancreatic duct or its branches. They are considered **true precursors** to invasive pancreatic adenocarcinoma. [1] The risk is particularly high in **Main-Duct IPMNs** (up to 60-70% malignancy risk) compared to branch-duct types. They often harbor *GNAS* and *KRAS* mutations, marking a high potential for dysplastic progression. [1] **2. Analysis of Incorrect Options:** * **Pseudopancreatic cyst:** These are **non-neoplastic** inflammatory collections of fluid and debris lacking an epithelial lining (lined by granulation tissue). [2] They occur post-pancreatitis and have **zero** malignant potential. * **Serous cystic neoplasms (SCN):** These are almost always **benign**. [1] They are lined by glycogen-rich cuboidal cells (honeycomb appearance) and are associated with *VHL* gene mutations. Malignant transformation is exceedingly rare (<1%). * **Mucinous cystic neoplasms (MCN):** While these are precursors to adenocarcinoma, they are generally considered to have a **lower overall risk** than main-duct IPMNs. [1] They occur almost exclusively in women and are characterized by "ovarian-type stroma." **3. NEET-PG High-Yield Pearls:** * **"Ovarian-type stroma"** is the pathognomonic histological feature of Mucinous Cystic Neoplasms. * **GNAS mutation** is highly specific for IPMNs. * **CEA levels** in cyst fluid: High in IPMN/MCN (mucinous); Low in SCN (serous). * **Location:** SCN and MCN are usually in the **tail/body**; IPMNs are more common in the **head** of the pancreas. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 895-897. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, p. 895.

Question 5: Which of the following statements is false regarding hereditary pancreatitis?

A. Mutation of the cationic trypsinogen gene
B. Autosomal recessive inheritance (Correct Answer)
C. Hereditary pancreatitis is associated with chromosome 7
D. Increased risk of pancreatic cancer

Explanation: ### Explanation: Hereditary Pancreatitis Hereditary pancreatitis is a rare genetic condition characterized by recurrent bouts of acute pancreatitis, often beginning in childhood, which frequently progresses to chronic pancreatitis. **1. Why Option B is the Correct (False) Statement:** Hereditary pancreatitis is primarily an **Autosomal Dominant** disorder with high penetrance (about 80%). It is not autosomal recessive. The most common cause is a "gain-of-function" mutation in the **PRSS1 gene**, which prevents the deactivation of trypsin, leading to autodigestion of the pancreas [1]. **2. Analysis of Other Options:** * **Option A (Mutation of cationic trypsinogen gene):** This is true. The **PRSS1 gene** (Protease Serine 1) encodes for cationic trypsinogen. Mutations (most commonly R122H) make trypsinogen resistant to cleavage by another enzyme (mesotrypsin or chymotrypsin C), keeping trypsin active and destructive [1]. * **Option C (Associated with chromosome 7):** This is true. The PRSS1 gene is located on the long arm of **Chromosome 7 (7q34)**. * **Option D (Increased risk of pancreatic cancer):** This is true. Patients with hereditary pancreatitis have a significantly elevated risk (estimated **40% to 50% lifetime risk**) of developing pancreatic adenocarcinoma [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gene involved:** PRSS1 (Gain-of-function) [1]. * **Other associated genes:** **SPINK1** (Serine protease inhibitor Kazal-type 1) and **CFTR** (Cystic Fibrosis Transmembrane Conductance Regulator) mutations are also linked to idiopathic/chronic pancreatitis, but PRSS1 is the hallmark of the hereditary form [1]. * **Clinical Presentation:** Early onset (usually <20 years) of recurrent epigastric pain. * **Management:** Primarily supportive; however, due to the high malignancy risk, regular screening and sometimes total pancreatectomy are considered. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 891-892.

Question 6: A 65-year-old woman presents with a 5-week history of yellow skin and sclera, anorexia, and epigastric pain. Her past medical history is significant for insulin-dependent diabetes mellitus. She smoked one pack of cigarettes a day for the past 20 years. Physical examination reveals jaundice and a palpable gallbladder. Laboratory studies show a serum bilirubin level of 10 mg/dL, mostly in the conjugated form, and an elevated alkaline phosphatase (260 U/L). A CT scan of the abdomen discloses a mass in the head of the pancreas and multiple nodules in the liver measuring up to 3 cm. Which of the following is the most likely cause of jaundice in this patient?

A. Cholelithiasis
B. Cirrhosis
C. Extrahepatic biliary obstruction (Correct Answer)
D. Hemolysis

Explanation: ### Explanation The clinical presentation of **painless jaundice**, weight loss (anorexia), and a **palpable gallbladder** (Courvoisier’s sign) in an elderly smoker with new-onset diabetes is classic for **adenocarcinoma of the head of the pancreas** [1]. **1. Why Extrahepatic Biliary Obstruction is Correct:** A mass in the head of the pancreas causes mechanical compression of the **distal common bile duct (CBD)** [2]. This leads to "Extrahepatic Biliary Obstruction," preventing the flow of bile into the duodenum [4]. This results in: * **Conjugated Hyperbilirubinemia:** Bilirubin is conjugated by the liver but cannot be excreted. * **Elevated Alkaline Phosphatase (ALP):** Obstruction triggers increased synthesis and release of ALP from the bile duct epithelium. * **Courvoisier’s Law:** A palpable, non-tender gallbladder in a jaundiced patient suggests malignant obstruction of the CBD rather than gallstones (as stones cause a fibrotic, non-distensible gallbladder). **2. Why Incorrect Options are Wrong:** * **Cholelithiasis:** While it causes obstructive jaundice, it usually presents with acute colicky pain and a non-palpable gallbladder [2]. It does not explain the pancreatic mass or liver nodules (metastases) [3]. * **Cirrhosis:** This causes intrahepatic jaundice with mixed hyperbilirubinemia and signs of portal hypertension (splenomegaly, ascites), not a localized pancreatic mass. * **Hemolysis:** This leads to **unconjugated hyperbilirubinemia** and normal ALP levels. **3. NEET-PG High-Yield Pearls:** * **Risk Factors for Pancreatic Cancer:** Smoking (strongest environmental factor), chronic pancreatitis, and DM. * **Tumor Marker:** **CA 19-9** (used for monitoring, not screening). * **Trousseau Sign:** Migratory thrombophlebitis associated with visceral malignancy (especially pancreas) [1]. * **Most common site:** Head of the pancreas (60%), leading to early jaundice. Body and tail lesions remain silent longer and present with metastases [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 899-900. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 403-404. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 408-409. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Liver and Gallbladder, pp. 866-868.

Question 7: A 45-year-old woman complains of right upper quadrant abdominal pain, weight loss, dry mouth, increased urine production, and foul-smelling fatty stools. She has a recent history of mild diabetes mellitus. Abdominal ultrasound examination reveals gallstones and a solitary 1.5-cm mass in the pancreas. Which of the following hormones would most likely be elevated in the blood of this patient?

A. Calcitonin
B. Gastrin
C. Insulin
D. Somatostatin (Correct Answer)

Explanation: ### Explanation The clinical presentation describes the classic **"Inhibitory Syndrome"** associated with a **Somatostatinoma**, a rare delta-cell neuroendocrine tumor of the pancreas. **1. Why Somatostatin is Correct:** Somatostatin is a potent universal inhibitor of gastrointestinal and pancreatic hormones. Its overproduction leads to a distinct clinical triad: * **Diabetes Mellitus:** Due to the inhibition of insulin secretion [2]. * **Cholelithiasis (Gallstones):** Due to the inhibition of Cholecystokinin (CCK) release, leading to gallbladder stasis. * **Steatorrhea (Fatty stools) & Hypochlorhydria:** Due to the inhibition of pancreatic enzyme secretion and gastrin, leading to malabsorption. The patient’s symptoms of dry mouth and polyuria are secondary to the induced diabetes [1]. **2. Why Incorrect Options are Wrong:** * **Calcitonin (A):** Secreted by medullary thyroid carcinoma. While part of MEN 2, it does not cause diabetes or gallstones. * **Gastrin (B):** Leads to **Zollinger-Ellison Syndrome**, characterized by refractory peptic ulcers and diarrhea, but not typically gallstones or diabetes [3]. * **Insulin (C):** An insulinoma would present with **Whipple’s Triad** (hypoglycemia symptoms, low blood glucose, and relief upon glucose administration), which contradicts this patient’s diabetic state [4]. **3. Clinical Pearls for NEET-PG:** * **Location:** Somatostatinomas are most commonly found in the **pancreas** (head) or the **duodenum**. * **Association:** They can be associated with **MEN 1** or **Neurofibromatosis type 1 (NF1)** [4]. * **Diagnosis:** Confirmed by fasting plasma somatostatin levels >160 pg/mL. * **Psammoma Bodies:** Histologically, duodenal somatostatinomas often uniquely exhibit psammoma bodies. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1116-1117. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 433-434. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1124-1125. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1125.

Question 8: Mucoviscidosis is most commonly related to which of the following conditions?

A. Fibrocystic disease of the pancreas (Correct Answer)
B. Duodenal atresia
C. Diaphragmatic hernia
D. Annular pancreas

Explanation: **Explanation:** **Mucoviscidosis** is the alternative medical term for **Cystic Fibrosis (CF)**. The name is derived from the production of abnormally thick, viscous mucus (*muco-*) that leads to the formation of cysts and extensive scarring (*-viscidosis*) in glandular organs [2]. **Why Option A is Correct:** In the pancreas, the primary defect involves mutations in the **CFTR gene** (most commonly **ΔF508**) [3]. This leads to defective chloride transport, resulting in dehydrated, inspissated secretions that plug the pancreatic ducts [4]. This obstruction causes atrophy of the exocrine acini and their replacement by fibrous tissue and multiple small cysts [5]. Hence, the classic pathological description of the pancreas in CF is **Fibrocystic disease of the pancreas**. **Why Other Options are Incorrect:** * **B. Duodenal atresia:** While CF is associated with *meconium ileus*, duodenal atresia is a congenital obstructive anomaly more commonly associated with **Down Syndrome**. * **C. Diaphragmatic hernia:** This is a structural defect in the diaphragm (e.g., Bochdalek hernia) and has no direct pathophysiological link to mucus viscosity or CFTR mutations. * **D. Annular pancreas:** This is a developmental anomaly where a ring of pancreatic tissue encircles the duodenum; it is not related to the systemic secretory defect seen in mucoviscidosis. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Autosomal Recessive; CFTR gene located on **Chromosome 7**. * **Diagnosis:** Sweat Chloride test (Gold Standard) showing chloride levels **>60 mEq/L** [4]. * **Pancreatic Impact:** Leads to malabsorption, steatorrhea, and deficiency of fat-soluble vitamins (A, D, E, K). * **Lungs:** Recurrent infections, bronchiectasis, and colonization by *Pseudomonas aeruginosa* [5]. * **Reproductive:** Bilateral absence of vas deferens (CBAVD) is a common finding in males [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 476-477. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 120-122. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 891-892. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Lumen Of Sweat Duct, pp. 475-476. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 477-478.

Question 9: What is the commonest type of pancreatic tumour?

A. Ductal adenocarcinoma (Correct Answer)
B. Cystadenoma
C. Insulinoma
D. Non-islet cell tumour

Explanation: **Ductal Adenocarcinoma** is the correct answer because it accounts for approximately **85-90% of all pancreatic neoplasms**. It originates from the exocrine portion of the pancreas, specifically the ductal epithelium [1]. It most commonly arises in the **head of the pancreas (60%)**, often leading to obstructive jaundice, which is a classic clinical presentation [3]. **Analysis of Incorrect Options:** * **B. Cystadenoma:** These are cystic neoplasms (e.g., Serous or Mucinous). While they are important differential diagnoses for pancreatic masses, they are significantly rarer than solid ductal carcinomas [4]. * **C. Insulinoma:** This is the most common **Pancreatic Neuroendocrine Tumor (PanNET)**, but PanNETs as a whole represent only about 1–2% of all pancreatic tumors. * **D. Non-islet cell tumour:** This is a broad category that could include various mesenchymal or secondary tumors, none of which approach the prevalence of ductal adenocarcinoma. **High-Yield Clinical Pearls for NEET-PG:** * **Risk Factors:** Smoking (strongest environmental link), chronic pancreatitis, and diabetes mellitus. * **Genetic Mutations:** **KRAS** (most common, >90%), CDKN2A (p16), TP53, and SMAD4 [1]. * **Tumor Marker:** **CA 19-9** (used for monitoring response to therapy, not for primary screening). * **Morphology:** Characterized by a dense **desmoplastic response** (fibrous stroma), making the tumor hard and gritty [2]. * **Trousseau Sign:** Migratory thrombophlebitis is a classic paraneoplastic syndrome associated with pancreatic cancer [3]. * **Courvoisier’s Law:** A palpable, non-tender gallbladder in a jaundiced patient suggests obstruction due to a malignancy (like pancreatic head cancer) rather than gallstones. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 897-898. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 408-409. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 899-900. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 895-897.

Question 10: Which of the following statements about autoimmune pancreatitis are true?

A. It is associated with other autoimmune disorders
B. Obstructive jaundice is a feature
C. Elevated serum IGM 4 is a marker
D. Distinct enlargement of the head of the pancreas in CT abdomen is seen, and glucocorticoids are effective in alleviating symptoms (Correct Answer)

Explanation: **Autoimmune Pancreatitis (AIP)** is a distinct form of chronic pancreatitis characterized by an autoimmune-mediated inflammatory process. It is primarily classified into two types, with **Type 1** being the most common, representing a systemic **IgG4-related disease** [1]. ### **Why Option D is Correct** * **Imaging:** On CT, AIP typically presents with diffuse or focal enlargement of the pancreas. Focal enlargement, particularly of the **pancreatic head**, can mimic pancreatic carcinoma (the "sausage-shaped" pancreas). * **Treatment:** A hallmark of AIP is its **dramatic response to glucocorticoids**. Steroids lead to rapid resolution of symptoms, biochemical markers, and radiological abnormalities, often serving as a diagnostic trial. ### **Analysis of Incorrect Options** * **Option A:** While AIP is an autoimmune condition, it is specifically part of the **IgG4-related fibroinflammatory spectrum** (affecting bile ducts, salivary glands, and retroperitoneum) rather than being broadly associated with classic autoimmune disorders like SLE or Rheumatoid Arthritis. * **Option B:** While obstructive jaundice *can* occur due to the enlargement of the pancreatic head or associated sclerosing cholangitis, it is a **clinical manifestation**, not a defining pathological statement compared to the specific radiological and therapeutic profile mentioned in Option D [2]. * **Option C:** The specific serological marker is **elevated Serum IgG4**, not IgM4. This is a high-yield distinction for exams [1]. ### **Clinical Pearls for NEET-PG** * **Histopathology:** Look for **"Lymphoplasmacytic Sclerosing Pancreatitis" (LPSP)**, characterized by a dense "storiform" fibrosis and obliterative phlebitis. * **Radiology:** The classic description is a **"Sausage-shaped pancreas"** with a loss of normal lobularity and a peripancreatic "halo" (rim of edema). * **Markers:** Elevated **IgG4 levels** (>135 mg/dL) are seen in ~70% of Type 1 cases [1]. * **Differential:** Always rule out pancreatic adenocarcinoma before starting steroids, as both can present with a mass in the pancreatic head [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 893-895. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Pancreas, pp. 899-900.

Practice by Chapter

Congenital Anomalies of Pancreas

Practice Questions

Acute Pancreatitis

Practice Questions

Chronic Pancreatitis

Practice Questions

Pancreatic Neoplasms

Practice Questions

Cystic Lesions of Pancreas

Practice Questions

Endocrine Tumors of Pancreas

Practice Questions

Pancreatic Manifestations of Systemic Diseases

Practice Questions

Pancreatic Transplantation Pathology

Practice Questions

Pancreatic Pseudocysts

Practice Questions

Laboratory Assessment of Pancreatic Diseases

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free